PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
PacBio (NASDAQ: PACB) management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on March 2, 2026 at 2:30 PM ET in Boston.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PacBio (NASDAQ: PACB) management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on March 2, 2026 at 2:30 PM ET in Boston.
A live webcast will be available on the company's investor site and a replay will be accessible for at least 30 days, according to PacBio.
Details
News Market Reaction – PACB
On Feb 19, the first trading day after this news, PACB closed 3.07% above the previous close.
Data tracked by StockTitan Argus for the Feb 19 session.
Key Figures
- Conference edition
- 46th annual
- TD Cowen Health Care Conference
- Conference date
- March 2, 2026
- TD Cowen 46th Annual Health Care Conference
- Event time
- 2:30 PM ET
- Scheduled fireside chat time
- Webcast replay period
- 30 days
- Replay availability following the event
Historical Context
-
Reported Q4 and full‑year 2025 revenue growth with improved non‑GAAP margins.
-
Joined iHope initiative as first long‑read sequencing partner for rare diseases.
-
Completed sale of short‑read assets to Illumina, receiving $48.1M net cash.
-
Announced date and access details for Q4 and full‑year 2025 results call.
-
Planned collaboration using HiFi long‑read sequencing for ultra‑rare genetic diseases.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026, at 2:30 PM ET in Boston, MA.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.